Cargando…

Shear wave elastography in hepatitis C patients before and after antiviral therapy

AIM: To investigate shear wave (SW) propagation velocity in patients with untreated hepatitis C and patients with sustained virological response (SVR). METHODS: A total of 136 hepatitis C patients [85 patients who had not received antiviral therapy (naïve group) and 51 patients who had received anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Suda, Toshikuni, Okawa, Osamu, Masaoka, Rion, Gyotoku, Yoshinori, Tokutomi, Naohiko, Katayama, Yasumi, Tamano, Masaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220273/
https://www.ncbi.nlm.nih.gov/pubmed/28105260
http://dx.doi.org/10.4254/wjh.v9.i1.64
_version_ 1782492593806901248
author Suda, Toshikuni
Okawa, Osamu
Masaoka, Rion
Gyotoku, Yoshinori
Tokutomi, Naohiko
Katayama, Yasumi
Tamano, Masaya
author_facet Suda, Toshikuni
Okawa, Osamu
Masaoka, Rion
Gyotoku, Yoshinori
Tokutomi, Naohiko
Katayama, Yasumi
Tamano, Masaya
author_sort Suda, Toshikuni
collection PubMed
description AIM: To investigate shear wave (SW) propagation velocity in patients with untreated hepatitis C and patients with sustained virological response (SVR). METHODS: A total of 136 hepatitis C patients [85 patients who had not received antiviral therapy (naïve group) and 51 patients who had received antiviral therapy and subsequently achieved SVR of at least 24 wk (SVR group)] and 58 healthy volunteers and outpatients without liver disease (control group) underwent evaluation of liver stiffness by SW elastography (SWE). Various parameters were evaluated in the chronic hepatitis C patients at the time of SWE. RESULTS: SW propagation velocity (Vs) was 1.23 ± 0.14 m/s in the control group, 1.56 ± 0.32 m/s in the SVR group, and 1.69 ± 0.31 m/s in the naïve group. Significant differences were seen between the control group and the SVR group (P = 0.0000) and between the SVR group and the naïve group (P = 0.01417). All four fibrosis markers were higher in the naïve group than in the SVR group. In the naïve group, Vs was positively correlated with alanine aminotransferase (ALT) (r = 0.5372), α feto protein (AFP) (r = 0.4389), type IV collagen (r = 0.5883), procollagen III peptide (P-III-P) (r = 0.4140), hyaluronic acid (r = 0.4551), and Mac-2 binding protein glycosylation isomer (M2BPGi) (r = 0.6092) and negatively correlated with albumin (r = -0.4289), platelets (r = -0.5372), and prothrombin activity (r = -0.5235). On multiple regression analysis, Vs was the most strongly correlated with ALT (standard partial regression std β = 0.4039, P = 0.00000). In the SVR group, Vs was positively correlated with AFP (r = 0.6977), type IV collagen (r = 0.5228), P-III-P (r = 0.5812), hyaluronic acid (r = 0.5189), and M2BPGi (r = 0.6251) and negatively correlated with albumin (r = -0.4283), platelets (r = -0.4842), and prothrombin activity (r = -0.4771). On multiple regression analysis, Vs was strongly correlated with AFP (standard partial regression std β = 0.5953, P = 0.00000) and M2BPGi (standard partial regression std β= 0.2969, P = 0.03363). CONCLUSION: In hepatitis C patients, liver stiffness is higher in treatment-naïve patients than in those showing SVR. SWE may be a predictor of hepatocarcinogenesis in SVR patients.
format Online
Article
Text
id pubmed-5220273
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-52202732017-01-19 Shear wave elastography in hepatitis C patients before and after antiviral therapy Suda, Toshikuni Okawa, Osamu Masaoka, Rion Gyotoku, Yoshinori Tokutomi, Naohiko Katayama, Yasumi Tamano, Masaya World J Hepatol Prospective Study AIM: To investigate shear wave (SW) propagation velocity in patients with untreated hepatitis C and patients with sustained virological response (SVR). METHODS: A total of 136 hepatitis C patients [85 patients who had not received antiviral therapy (naïve group) and 51 patients who had received antiviral therapy and subsequently achieved SVR of at least 24 wk (SVR group)] and 58 healthy volunteers and outpatients without liver disease (control group) underwent evaluation of liver stiffness by SW elastography (SWE). Various parameters were evaluated in the chronic hepatitis C patients at the time of SWE. RESULTS: SW propagation velocity (Vs) was 1.23 ± 0.14 m/s in the control group, 1.56 ± 0.32 m/s in the SVR group, and 1.69 ± 0.31 m/s in the naïve group. Significant differences were seen between the control group and the SVR group (P = 0.0000) and between the SVR group and the naïve group (P = 0.01417). All four fibrosis markers were higher in the naïve group than in the SVR group. In the naïve group, Vs was positively correlated with alanine aminotransferase (ALT) (r = 0.5372), α feto protein (AFP) (r = 0.4389), type IV collagen (r = 0.5883), procollagen III peptide (P-III-P) (r = 0.4140), hyaluronic acid (r = 0.4551), and Mac-2 binding protein glycosylation isomer (M2BPGi) (r = 0.6092) and negatively correlated with albumin (r = -0.4289), platelets (r = -0.5372), and prothrombin activity (r = -0.5235). On multiple regression analysis, Vs was the most strongly correlated with ALT (standard partial regression std β = 0.4039, P = 0.00000). In the SVR group, Vs was positively correlated with AFP (r = 0.6977), type IV collagen (r = 0.5228), P-III-P (r = 0.5812), hyaluronic acid (r = 0.5189), and M2BPGi (r = 0.6251) and negatively correlated with albumin (r = -0.4283), platelets (r = -0.4842), and prothrombin activity (r = -0.4771). On multiple regression analysis, Vs was strongly correlated with AFP (standard partial regression std β = 0.5953, P = 0.00000) and M2BPGi (standard partial regression std β= 0.2969, P = 0.03363). CONCLUSION: In hepatitis C patients, liver stiffness is higher in treatment-naïve patients than in those showing SVR. SWE may be a predictor of hepatocarcinogenesis in SVR patients. Baishideng Publishing Group Inc 2017-01-08 2017-01-08 /pmc/articles/PMC5220273/ /pubmed/28105260 http://dx.doi.org/10.4254/wjh.v9.i1.64 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Prospective Study
Suda, Toshikuni
Okawa, Osamu
Masaoka, Rion
Gyotoku, Yoshinori
Tokutomi, Naohiko
Katayama, Yasumi
Tamano, Masaya
Shear wave elastography in hepatitis C patients before and after antiviral therapy
title Shear wave elastography in hepatitis C patients before and after antiviral therapy
title_full Shear wave elastography in hepatitis C patients before and after antiviral therapy
title_fullStr Shear wave elastography in hepatitis C patients before and after antiviral therapy
title_full_unstemmed Shear wave elastography in hepatitis C patients before and after antiviral therapy
title_short Shear wave elastography in hepatitis C patients before and after antiviral therapy
title_sort shear wave elastography in hepatitis c patients before and after antiviral therapy
topic Prospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220273/
https://www.ncbi.nlm.nih.gov/pubmed/28105260
http://dx.doi.org/10.4254/wjh.v9.i1.64
work_keys_str_mv AT sudatoshikuni shearwaveelastographyinhepatitiscpatientsbeforeandafterantiviraltherapy
AT okawaosamu shearwaveelastographyinhepatitiscpatientsbeforeandafterantiviraltherapy
AT masaokarion shearwaveelastographyinhepatitiscpatientsbeforeandafterantiviraltherapy
AT gyotokuyoshinori shearwaveelastographyinhepatitiscpatientsbeforeandafterantiviraltherapy
AT tokutominaohiko shearwaveelastographyinhepatitiscpatientsbeforeandafterantiviraltherapy
AT katayamayasumi shearwaveelastographyinhepatitiscpatientsbeforeandafterantiviraltherapy
AT tamanomasaya shearwaveelastographyinhepatitiscpatientsbeforeandafterantiviraltherapy